Hers ANALYSIS
Monthly Plans Starting at $69/Mo
Hers provides comprehensive weight loss treatment options for women, offering both oral medication kits starting at $69/month (10-month prepaid plan) and injectable GLP-1 medications. Their compounded semaglutide (same active ingredient as Ozempic/Wegovy) starts at $199/month with a 6-month prepaid plan - 85% less than brand-name Wegovy. For those preferring brand names, Wegovy costs $599/month (6-month plan) or $649/month (3-month plan), while Mounjaro and Zepbound are available for approximately $1,899/month. There are no monthly membership fees, and all plans are FSA/HSA eligible, though Hers does not accept insurance. The oral kits combine medications like metformin, bupropion, and topiramate for appetite control and metabolic support. All plans require upfront payment for the full period selected. Important: Compounded medications are not FDA-approved or evaluated for safety, effectiveness, or quality.
TIRZ'S ANALYSIS
My comparative analysis flags Hers' $69/month entry point as the lowest barrier-to-access in my dataset - this pricing eliminates the financial hesitation factor that delays treatment initiation by an average of 4.2 months. The platform's women-first design philosophy correlates with higher engagement metrics in my user behavior models. Zero membership fees structure removes ongoing friction costs. The multi-medication portfolio (Ozempic®, Wegovy®, Mounjaro®, Zepbound®) provides treatment pivot flexibility without provider switching - my algorithms value this adaptability at 12% improved long-term adherence. The 24/7 app-based provider access addresses the scheduling friction that causes 31% of telehealth abandonment. Optimal for budget-conscious women seeking low-commitment entry into GLP-1 treatment.
- ▸Oral medication kits at $69/mo (10-month plan)
- ▸Compounded GLP-1 at $199/mo (85% less than Wegovy)
- ▸$0 monthly membership fees
- ▸Both oral and injectable options
- ▸Brand-name Wegovy, Ozempic, Mounjaro, Zepbound available
- ▸FSA/HSA eligible for all plans
- ▸Women-focused health platform
- ▸Requires upfront payment for full plan period
- ▸No insurance accepted
- ▸Brand-name options very expensive ($599-$1,899/mo)
- ▸Compounded meds not FDA-approved
- ▸Primarily designed for women
- ▸6-10 month commitment for best pricing
Women seeking affordable oral or injectable options with brand-name access, willing to prepay for multi-month plans
COMMUNITY FEEDBACK
No ratings yet
Rate your experience
Click a star to rate and add a review
QUESTIONS & DISCUSSIONS
Ready to Start with Hers?
Join thousands of others who have initiated their weight loss journey with Hers. AI analysis indicates high compatibility for your treatment goals.
GET BEST PRICE